R
Rhonda Roberts
Researcher at Durham University
Publications - 39
Citations - 1916
Rhonda Roberts is an academic researcher from Durham University. The author has contributed to research in topics: Integrative medicine & Psychosocial. The author has an hindex of 16, co-authored 39 publications receiving 1623 citations. Previous affiliations of Rhonda Roberts include University of South Carolina & Duke University.
Papers
More filters
Journal ArticleDOI
Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials.
Joyce S. Lee,Harold R. Collard,Kevin J. Anstrom,Fernando J. Martinez,Imre Noth,Rhonda Roberts,Eric Yow,Ganesh Raghu +7 more
TL;DR: Investigation of data from three randomised controlled trials found anti-acid treatment could be beneficial in patients with IPF, and abnormal acid gastro-oesophageal reflux seems to contribute to disease progression.
Journal ArticleDOI
Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice
Boyd Yount,Rhonda Roberts,Amy C. Sims,Damon Deming,Matthew B. Frieman,Jennifer S. Sparks,Mark R. Denison,Nancy L. Davis,Ralph S. Baric +8 more
TL;DR: Deletion of the group-specific ORFs of SARS-CoV did not dramatically influence replication efficiency in cell culture or in the levels of viral RNA synthesis, and data suggest that ORF3a plays little role in the targeting of S localization in the rER/Golgi apparatus.
Journal ArticleDOI
Analysis of Intraviral Protein-Protein Interactions of the SARS Coronavirus ORFeome
Albrecht von Brunn,Carola Teepe,Jeremy C. Simpson,Rainer Pepperkok,Caroline C. Friedel,Ralf Zimmer,Rhonda Roberts,Ralph S. Baric,Juergen Haas +8 more
TL;DR: It is shown that also accessory protein ORF9b does not play a pivotal role for viral replication, as it can be deleted from the virus displaying normal plaque sizes and growth characteristics in Vero cells.
Journal ArticleDOI
Efficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart Failure
G. Michael Felker,Robert J. Mentz,Robert T. Cole,Kirkwood F. Adams,Gregory F. Egnaczyk,Mona Fiuzat,Chetan B. Patel,Melvin R. Echols,Michel G. Khouri,James M. Tauras,Divya Gupta,Pamela Monds,Rhonda Roberts,Christopher M. O'Connor +13 more
TL;DR: In patients hospitalized with AHF, dyspnea, and congestion, the addition of tolvaptan to a standardized furosemide regimen did not improve the number of responders at 24 h, despite greater weight loss and fluid loss.
Journal ArticleDOI
Noninvasive FFR Derived From Coronary CT Angiography: Management and Outcomes in the PROMISE Trial
Michael T. Lu,Maros Ferencik,Rhonda Roberts,Kerry L. Lee,Alexander Ivanov,Elizabeth C. Adami,Daniel B. Mark,Farouc A. Jaffer,Jonathon Leipsic,Pamela S. Douglas,Udo Hoffmann +10 more
TL;DR: In this hypothesis-generating study of patients with stable chest pain referred to ICA from CTA, an FFRCT of ≤0.80 was a better predictor of revascularization or major adverse cardiac events than severe stenosis on CTA.